Metabolites in class phenol

Metabolite ID	Metabolite Name	Molecular Formula	Average Mass
BASm0008307	(S)-nandinine	C₁₉H₁₉NO₄	325.364
BASm0009783	guaethol	C₈H₁₀O₂	138.1638
BASm0010750	(3S)-9,10-dihydroxy-7-methoxy-3-(2-oxopropyl)-1H,3H,4H-naphtho[2,3-c]pyran-1-one	C₁₇H₁₆O₆	316.309
BASm0010753	1-(3,4,5-trihydroxy-7-methoxynaphthalen-2-yl)propan-2-one	C₁₄H₁₄O₅	262.261
BASm0010794	2,3,6,8,9-pentahydroxy-3-(2-oxopropyl)-1,2,3,4-tetrahydroanthracen-1-one	C₁₇H₁₆O₇	332.308
BASm0011013	(3R)-3,8,9,10-tetrahydroxy-6-methyl-1,2,3,4-tetrahydroanthracen-1-one	C₁₅H₁₄O₅	274.272
BASm0012562	(8S)-annullatin E	C₁₂H₁₈O₃	210.273
BASm0012563	(8S)-annullatin J	Not Available	Not Available
BASm0013035	(E)-ferulic acid beta-D-glucuronate ester	C₁₆H₁₈O₁₀	370.31
BASm0013215	1'-carboxy-chondrochloren A	Not Available	Not Available
BASm0013216	1'-carboxy-chondrochloren B	Not Available	Not Available
BASm0001468	(E)-sinapaldehyde	C₁₁H₁₂O₄	208.2106
BASm0001922	2,4'-dihydroxyacetophenone	C₈H₈O₃	152.1473
BASm0002334	(6aS,11aS)-4-dimethylallyl-3,6a,9-trihydroxypterocarpan	C₂₀H₂₀O₅	340.1311
BASm0002349	(6aS,11aS)-2-dimethylallyl-3,6a,9-trihydroxypterocarpan	C₂₀H₂₀O₅	340.1311
BASm0013244	2'-O-methylisoliquiritigenin	C₁₆H₁₄O₄	270.28
BASm0004838	(+)-larreatricin	C₁₈H₂₀O₃	284.355
BASm0004854	(-)-lariciresinol	C₂₀H₂₄O₆	360.4
BASm0004856	(+)-lariciresinol	C₂₀H₂₄O₆	360.401
BASm0005574	2-amino-5-chlorophenol	C₆H₆ClNO	143.57
BASm0006744	1-O-[(E)-feruloyl]-beta-D-glucose	C₁₆H₂₀O₉	356.3246
BASm0007238	13-hydroxy-alpha-tocopherol	C₂₉H₅₀O₃	446.7055
BASm0007239	13-hydroxy-gamma-tocopherol	C₂₈H₄₈O₃	432.6789
BASm0007647	15alpha-hydroxy-17beta-estradiol	C₁₈H₂₄O₃	288.387
BASm0007653	15alpha-hydroxyestrone	C₁₈H₂₂O₃	286.371
BASm0007654	16beta,17beta-estriol	C₁₈H₂₄O₃	288.3814
BASm0008006	(-)-5'-demethylyatein	C₂₁H₂₂O₇	386.4
BASm0008007	(-)-pluviatolide	C₂₀H₂₀O₆	356.374

We require the use of cookies for essential features like storing your previously submitted BASys2 queries. Rejecting the usage of cookies will result in certain features being disabled. By clicking ACCEPT or continuing to use the website you are agreeing to our use of cookies.